On the public citation graph

Radiometals for imaging and theranostics, current production, and future perspectives

0 signed · 223 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cmdc.201200471openalex-snapshot
How is 68Ga Labeling of Macrocyclic Chelators Influenced by Metal Ion Contaminants in 68Ge/68Ga Generator Eluates?
inferredcites →https://doi.org/10.1002/jlcr.3582openalex-snapshot
Re‐thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals
inferredcites →https://doi.org/10.1007/978-3-642-27994-2_28openalex-snapshot
Intraoperative Somatostatin Receptor Detection After Peptide Receptor Radionuclide Therapy with 177Lu- and 90Y-DOTATOC (Tandem PRRNT) in a Patient with a Metastatic Neuroendocrine Tumor
inferredcites →https://doi.org/10.1007/bf00879669openalex-snapshot
DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy
inferredcites →https://doi.org/10.1007/bf02586901openalex-snapshot
Internal radiation therapy of hepatic cancer
inferredcites →https://doi.org/10.1007/s00259-011-1771-7openalex-snapshot
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?
inferredcites →https://doi.org/10.1007/s00259-011-1833-xopenalex-snapshot
Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?
inferredcites →https://doi.org/10.1007/s00259-011-2039-yopenalex-snapshot
Lutetium-labelled peptides for therapy of neuroendocrine tumours
inferredcites →https://doi.org/10.1007/s00259-013-2563-zopenalex-snapshot
Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate
inferredcites →https://doi.org/10.1007/s00259-018-4029-9openalex-snapshot
Highlights of the 30th Annual Congress of the EANM, Vienna 2017: “Yes we can – make nuclear medicine great again”
inferredcites →https://doi.org/10.1007/s10549-018-4696-zopenalex-snapshot
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer
inferredcites →https://doi.org/10.1007/s10967-014-3777-7openalex-snapshot
Isolation of generator-produced 223Ra in 0.9-% NaCl solutions containing EDTA for direct radiotherapeutic studies
inferredcites →https://doi.org/10.1007/s10967-015-4039-zopenalex-snapshot
Accelerator-based photoproduction of promising beta-emitters 67Cu and 47Sc
inferredcites →https://doi.org/10.1007/s10967-017-5321-zopenalex-snapshot
47Sc production development by cyclotron irradiation of 48Ca
inferredcites →https://doi.org/10.1007/s11307-017-1121-7openalex-snapshot
A PSMA Ligand Labeled with Cobalt-55 for PET Imaging of Prostate Cancer
inferredcites →https://doi.org/10.1007/s13139-014-0315-zopenalex-snapshot
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
inferredcites →https://doi.org/10.1016/0010-8545(93)85046-7openalex-snapshot
Perspectives on bioinorganic chemistry
inferredcites →https://doi.org/10.1016/0020-708x(60)90052-1openalex-snapshot
A positron cow
inferredcites →https://doi.org/10.1016/0020-708x(77)90178-8openalex-snapshot
Preparation of carrier-free 47Sc by the 48Ti (γ,p) reaction
inferredcites →https://doi.org/10.1016/0020-708x(78)90127-8openalex-snapshot
Preparation of carrier-free 67Cu by the 68Zn(γ,p) reaction
inferredcites →https://doi.org/10.1016/0883-2889(86)90192-9openalex-snapshot
Production of no-carrier added 67Cu
inferredcites →https://doi.org/10.1016/0883-2889(92)90050-oopenalex-snapshot
Improved chemistry for the production of yttrium-90 for medical applications
inferredcites →https://doi.org/10.1016/0883-2897(86)90027-9openalex-snapshot
The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine
inferredcites →https://doi.org/10.1016/0969-8043(93)90101-fopenalex-snapshot
Preparation of carrier-free yttrium-90 for medical applications by solvent extraction chromatography
inferredcites →https://doi.org/10.1016/0969-8043(93)90131-sopenalex-snapshot
Production of the positron emitting radioisotope 86Y for nuclear medical application
inferredcites →https://doi.org/10.1016/j.apradiso.2004.06.013openalex-snapshot
Cyclotron production of Ac-225 for targeted alpha therapy11Dedicated to Prof. Dr. Franz Baumgärtner on the occasion of his 75th birthday.
inferredcites →https://doi.org/10.1016/j.apradiso.2004.12.003openalex-snapshot
Production of actinium-225 for alpha particle mediated radioimmunotherapy
inferredcites →https://doi.org/10.1016/j.apradiso.2005.02.005openalex-snapshot
A process for the separation of 177Lu from neutron irradiated 176Yb targets
inferredcites →https://doi.org/10.1016/j.apradiso.2005.12.021openalex-snapshot
Cyclotron production of 64Cu by deuteron irradiation of 64Zn
inferredcites →https://doi.org/10.1016/j.apradiso.2007.03.018openalex-snapshot
Production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226
inferredcites →https://doi.org/10.1016/j.apradiso.2007.06.003openalex-snapshot
55Cobalt complexes with pendant carbohydrates as potential PET imaging agents
inferredcites →https://doi.org/10.1016/j.apradiso.2007.08.013openalex-snapshot
Production of 177Lu at the new research reactor FRM-II: Irradiation yield of 176Lu177Lu
inferredcites →https://doi.org/10.1016/j.apradiso.2008.02.058openalex-snapshot
Target burn-up corrected specific activity of 177Lu produced via 176Lu(n, γ) 177Lu nuclear reactions
inferredcites →https://doi.org/10.1016/j.apradiso.2008.11.009openalex-snapshot
Study of the excitation function for the deuteron induced reaction on 64Ni(d,2n) for the production of the medical radioisotope 64Cu
inferredcites →https://doi.org/10.1016/j.apradiso.2009.06.005openalex-snapshot
Rapid determination of 90Sr impurities in freshly “generator eluted” 90Y for radiopharmaceutical preparation
inferredcites →https://doi.org/10.1016/j.apradiso.2010.04.003openalex-snapshot
Post-elution processing of 44Ti/44Sc generator-derived 44Sc for clinical application
inferredcites →https://doi.org/10.1016/j.apradiso.2011.01.028openalex-snapshot
The use of selective volatization in the separation of 68Ge from irradiated Ga targets
inferredcites →https://doi.org/10.1016/j.apradiso.2011.10.007openalex-snapshot
Development of a large scale production of 67Cu from 68Zn at the high energy proton accelerator: Closing the 68Zn cycle
inferredcites →https://doi.org/10.1016/j.apradiso.2012.01.019openalex-snapshot
Module-assisted preparation of 64Cu with high specific activity
inferredcites →https://doi.org/10.1016/j.apradiso.2012.03.009openalex-snapshot
A semi-automated system for the routine production of copper-64
inferredcites →https://doi.org/10.1016/j.apradiso.2012.04.030openalex-snapshot
Cyclotron produced 44gSc from natural calcium
inferredcites →https://doi.org/10.1016/j.apradiso.2012.07.009openalex-snapshot
The production, separation, and use of 67Cu for radioimmunotherapy: A review
inferredcites →https://doi.org/10.1016/j.apradiso.2013.08.010openalex-snapshot
Influence of metal ions on the 68Ga-labeling of DOTATATE
inferredcites →https://doi.org/10.1016/j.apradiso.2014.12.020openalex-snapshot
47Ca production for 47Ca/47Sc generator system using electron linacs
inferredcites →https://doi.org/10.1016/j.apradiso.2015.04.012openalex-snapshot
Sc-47 production from titanium targets using electron linacs
inferredcites →https://doi.org/10.1016/j.apradiso.2015.11.058openalex-snapshot
Evaluation of nuclear reaction cross sections for optimization of production of the emerging diagnostic radionuclide 55 Co
inferredcites →https://doi.org/10.1016/j.apradiso.2016.05.028openalex-snapshot
Lu-177 preparation for radiotherapy application
inferredcites →https://doi.org/10.1016/j.apradiso.2016.07.001openalex-snapshot
Production of medical Sc radioisotopes with an alpha particle beam
inferredcites →https://doi.org/10.1016/j.apradiso.2016.07.017openalex-snapshot
Production of scandium-43 and -47 from a powdery calcium oxide target via the nat/44Ca(α,x)-channel
inferredcites →https://doi.org/10.1016/j.apradiso.2016.09.026openalex-snapshot
Large scale accelerator production of 225Ac: Effective cross sections for 78–192 MeV protons incident on 232Th targets
inferredcites →https://doi.org/10.1016/j.apradiso.2017.03.020openalex-snapshot
Evaluation of the separation and purification of 227 Th from its decay progeny by anion exchange and extraction chromatography
inferredcites →https://doi.org/10.1016/j.apradiso.2017.09.005openalex-snapshot
Cyclotron production and radiochemical separation of 55Co and 58mCo from 54Fe, 58Ni and 57Fe targets
inferredcites →https://doi.org/10.1016/j.apradiso.2017.11.019openalex-snapshot
The feasibility study of 177 Lu production in Miniature Neutron Source Reactors using a multi-stage approach in Isfahan, Iran
inferredcites →https://doi.org/10.1016/j.apradiso.2018.03.007openalex-snapshot
64 Cu, a powerful positron emitter for immunoimaging and theranostic: Production via nat ZnO and nat ZnO-NPs
inferredcites →https://doi.org/10.1016/j.apradiso.2018.09.016openalex-snapshot
Simplified and automatable radiochemical separation strategy for the production of radiopharmaceutical quality 86Y using single column extraction chromatography
inferredcites →https://doi.org/10.1016/j.apradiso.2018.10.015openalex-snapshot
Cross-section measurement of 44Sc,47Sc, 48Sc and 47Ca for an optimized 47Sc production with an 18 MeV medical PET cyclotron
inferredcites →https://doi.org/10.1016/j.apradiso.2018.12.031openalex-snapshot
Measurement of the 43Sc production cross-section with a deuteron beam
inferredcites →https://doi.org/10.1016/j.bmcl.2016.07.034openalex-snapshot
An efficient chelator for complexation of thorium-227
inferredcites →https://doi.org/10.1016/j.chroma.2018.02.053openalex-snapshot
Optimized anion exchange column isolation of zirconium-89 (89Zr) from yttrium cyclotron target: Method development and implementation on an automated fluidic platform
inferredcites →https://doi.org/10.1016/j.clineuro.2003.10.001openalex-snapshot
Cobalt-55 positron emission tomography in symptomatic atherosclerotic carotid artery disease: borderzone versus territorial infarcts
inferredcites →https://doi.org/10.1016/j.nucmedbio.2004.05.001openalex-snapshot
227Th-EDTMP: A potential therapeutic agent for bone metastasis
inferredcites →https://doi.org/10.1016/j.nucmedbio.2005.09.006openalex-snapshot
Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin
inferredcites →https://doi.org/10.1016/j.nucmedbio.2005.12.004openalex-snapshot
Initial evaluation of 227Th-p-benzyl-DOTA-rituximab for low-dose rate α-particle radioimmunotherapy
inferredcites →https://doi.org/10.1016/j.nucmedbio.2007.10.009openalex-snapshot
Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy
inferredcites →https://doi.org/10.1016/j.nucmedbio.2009.05.007openalex-snapshot
Standardized methods for the production of high specific-activity zirconium-89
inferredcites →https://doi.org/10.1016/j.nucmedbio.2011.02.007openalex-snapshot
The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy
inferredcites →https://doi.org/10.1016/j.nucmedbio.2011.10.015openalex-snapshot
Influence of cations on the complexation yield of DOTATATE with yttrium and lutetium: a perspective study for enhancing the 90Y and 177Lu labeling conditions
inferredcites →https://doi.org/10.1016/j.nucmedbio.2011.11.005openalex-snapshot
A historical perspective on the specific activity of radiopharmaceuticals: what have we learned in the 35 years of the ISRC?
inferredcites →https://doi.org/10.1016/j.nucmedbio.2012.12.010openalex-snapshot
A historical perspective on the specific activity of radiopharmaceuticals: What have we learned in the 35years of the ISRC?
inferredcites →https://doi.org/10.1016/j.nucmedbio.2014.01.006openalex-snapshot
Production of 89Zr via the 89Y(p,n)89Zr reaction in aqueous solution: Effect of solution composition on in-target chemistry
inferredcites →https://doi.org/10.1016/j.nucmedbio.2015.03.001openalex-snapshot
Production and separation of 186gRe from proton bombardment of 186WC
inferredcites →https://doi.org/10.1016/j.nucmedbio.2015.05.005openalex-snapshot
Cyclotron production of 44Sc: From bench to bedside
inferredcites →https://doi.org/10.1016/j.nucmedbio.2016.07.007openalex-snapshot
Efficient preparation of high-quality 64Cu for routine use
inferredcites →https://doi.org/10.1016/j.nucmedbio.2017.03.004openalex-snapshot
Production of Zr-89 using sputtered yttrium coin targets
inferredcites →https://doi.org/10.1016/j.nucmedbio.2017.09.004openalex-snapshot
Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight
inferredcites →https://doi.org/10.1016/j.nucmedbio.2018.01.002openalex-snapshot
Small-scale production of 67 Cu for a preclinical study via the 64 Ni(α, p) 67 Cu channel
inferredcites →https://doi.org/10.1016/j.nucmedbio.2018.06.001openalex-snapshot
Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer
inferredcites →https://doi.org/10.1016/j.talanta.2013.03.081openalex-snapshot
Determination of 90Sr traces in medical 90Y after separation on DGA column
inferredcites →https://doi.org/10.1016/s0022-510x(00)00382-8openalex-snapshot
Cobalt-55 positron emission tomography in late-onset epileptic seizures after thrombo-embolic middle cerebral artery infarction
inferredcites →https://doi.org/10.1016/s0022-510x(01)00606-2openalex-snapshot
Cobalt-55 positron emission tomography in vascular dementia: significance of white matter changes
inferredcites →https://doi.org/10.1016/s0140-6736(05)78355-0openalex-snapshot
Yttrium-90-labelled somatostatin-analogue for cancer treatment
inferredcites →https://doi.org/10.1016/s0969-8043(00)00164-0openalex-snapshot
Production of terbium-152 by heavy ion reactions and proton induced spallation
inferredcites →https://doi.org/10.1016/s0969-8043(02)00180-xopenalex-snapshot
Radionuclide production for therapeutic radiopharmaceuticals
inferredcites →https://doi.org/10.1016/s0969-8043(03)00151-9openalex-snapshot
Large-scale purification of 90Sr from nuclear waste materials for production of 90Y, a therapeutic medical radioisotope
inferredcites →https://doi.org/10.1016/s0969-8043(97)10119-1openalex-snapshot
Production of 55Co and 57Co via proton induced reactions on highly enriched 58Ni
inferredcites →https://doi.org/10.1016/s0969-8043(98)00016-5openalex-snapshot
Radiochemical purification of no-carrier-added scandium-47 for radioimmunotherapy
inferredcites →https://doi.org/10.1016/s0969-8043(98)00151-1openalex-snapshot
An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation
inferredcites →https://doi.org/10.1016/s0969-8043(99)00284-5openalex-snapshot
Radiochemical separation of no-carrier-added as produced via the process
inferredcites →https://doi.org/10.1016/s0969-8051(96)00157-6openalex-snapshot
Efficient production of high specific activity 64Cu using a biomedical cyclotron
inferredcites →https://doi.org/10.1016/s1062-239x(99)80029-7openalex-snapshot
The chemistry of rhenium in nuclear medicine
inferredcites →https://doi.org/10.1021/ac0580114openalex-snapshot
Production of Ac-225 from Th-229 for Targeted α Therapy
inferredcites →https://doi.org/10.1021/ac701651uopenalex-snapshot
Extraction Paper Chromatography Technique for the Radionuclidic Purity Evaluation of 90Y for Clinical Use
inferredcites →https://doi.org/10.1021/cr3003104openalex-snapshot
Radiometals for Combined Imaging and Therapy
inferredcites →https://doi.org/10.1021/cr900325hopenalex-snapshot
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
inferredcites →https://doi.org/10.1021/cr9804386openalex-snapshot
Therapeutic Radiopharmaceuticals
inferredcites →https://doi.org/10.1023/a:1024784924154openalex-snapshot
Reactor produced 177Lu of specific activity and purity suitable for medical applications
inferredcites →https://doi.org/10.1023/b:jrnc.0000034887.23530.f6openalex-snapshot
Determination of elemental and radionuclidic impurities in 177Lu used for labeling of radiopharmaceuticals
inferredcites →https://doi.org/10.1038/s41598-018-27454-6openalex-snapshot
Imaging EGFR and HER3 through 89Zr-labeled MEHD7945A (Duligotuzumab)
inferredcites →https://doi.org/10.1039/a827043zopenalex-snapshot
The biomedical chemistry of technetium and rhenium
inferredcites →https://doi.org/10.1039/c0dt01504kopenalex-snapshot
Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS
inferredcites →https://doi.org/10.1039/c7dt01936jopenalex-snapshot
Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152 Tb-DOTATOC
inferredcites →https://doi.org/10.1063/1.4773959openalex-snapshot
Copper-67 production on electron linacs—Photonuclear technology development
inferredcites →https://doi.org/10.1063/1.4983532openalex-snapshot
Cyclotron production of Ga-68 for human use from liquid targets: From theory to practice
inferredcites →https://doi.org/10.1088/0031-9155/53/20/008openalex-snapshot
Evaluation of quantitative90Y SPECT based on experimental phantom studies
inferredcites →https://doi.org/10.1089/cbr.2012.1285openalex-snapshot
Availability of Yttrium-90 from Strontium-90: A Nuclear Medicine Perspective
inferredcites →https://doi.org/10.1089/cbr.2016.2173openalex-snapshot
First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced 44 Sc-DOTATOC: A Proof-of-Concept Study
inferredcites →https://doi.org/10.1126/science.1064126openalex-snapshot
Tumor Therapy with Targeted Atomic Nanogenerators
inferredcites →https://doi.org/10.1134/s106636221605009xopenalex-snapshot
A modified electrochemical procedure for isolating 177Lu radionuclide
inferredcites →https://doi.org/10.1136/ard.42.2.132openalex-snapshot
Yttrium-90 therapy and 99MTc pertechnetate knee uptake measurements in the management of rheumatoid arthritis.
inferredcites →https://doi.org/10.1155/2015/481279openalex-snapshot
Theranostic Imaging of Yttrium-90
inferredcites →https://doi.org/10.1177/1536012117749726openalex-snapshot
Reversible Electroporation–Mediated Liposomal Doxorubicin Delivery to Tumors Can Be Monitored With 89 Zr-Labeled Reporter Nanoparticles
inferredcites →https://doi.org/10.1186/2191-219x-3-56openalex-snapshot
Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting
inferredcites →https://doi.org/10.1186/s13550-016-0171-1openalex-snapshot
Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of 161Tb-folate and 177Lu-folate
inferredcites →https://doi.org/10.1186/s13550-016-0189-4openalex-snapshot
Preclinical in vivo application of 152Tb-DOTANOC: a radiolanthanide for PET imaging
inferredcites →https://doi.org/10.1186/s13550-017-0257-4openalex-snapshot
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
inferredcites →https://doi.org/10.1186/s40658-015-0136-xopenalex-snapshot
Cyclotron production of 43Sc for PET imaging
inferredcites →https://doi.org/10.1186/s41181-016-0008-2openalex-snapshot
Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics
inferredcites →https://doi.org/10.1186/s41181-016-0013-5openalex-snapshot
44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations
inferredcites →https://doi.org/10.1186/s41181-017-0024-xopenalex-snapshot
47Sc as useful β–-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
inferredcites →https://doi.org/10.1186/s41181-017-0033-9openalex-snapshot
Production and separation of 43Sc for radiopharmaceutical purposes
inferredcites →https://doi.org/10.1186/s41181-018-0038-zopenalex-snapshot
Production of novel diagnostic radionuclides in small medical cyclotrons
inferredcites →https://doi.org/10.1259/bjr.20180074openalex-snapshot
Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application
inferredcites →https://doi.org/10.1259/bjr/33524085openalex-snapshot
Yttrium-90 internal pair production imaging using first generation PET/CT provides high-resolution images for qualitative diagnostic purposes
inferredcites →https://doi.org/10.12693/aphyspola.127.1471openalex-snapshot
Medical Radioisotopes Produced Using the Alpha Particle Beam from the Warsaw Heavy Ion Cyclotron
inferredcites →https://doi.org/10.1371/journal.pone.0009470openalex-snapshot
Molecular Optical Imaging with Radioactive Probes
inferredcites →https://doi.org/10.1515/ract-2017-2847openalex-snapshot
Production, separation and supply prospects of 67Cu with the development of fast neutron sources and photonuclear technology
inferredcites →https://doi.org/10.1524/ract.2001.89.10.661openalex-snapshot
223Ra for endoradiotherapeutic applications prepared from an immobilized227Ac/227Th source
inferredcites →https://doi.org/10.1524/ract.2001.89.4-5.297openalex-snapshot
Therapeutic radionuclides and nuclear data
inferredcites →https://doi.org/10.1524/ract.2002.90.5_2002.247openalex-snapshot
Production routes of the alpha emitting 149 Tb for medical application
inferredcites →https://doi.org/10.1524/ract.2010.1701openalex-snapshot
A 44Ti/44Sc radionuclide generator for potential application of 44Sc-based PET-radiopharmaceuticals
inferredcites →https://doi.org/10.1524/ract.2012.1938openalex-snapshot
New separation method of no-carrier-added 47Sc from titanium targets
inferredcites →https://doi.org/10.1524/ract.2012.1939openalex-snapshot
Preparation of67Cuviadeuteron irradiation of70Zn
inferredcites →https://doi.org/10.1524/ract.2013.2032openalex-snapshot
Cyclotron production of 44Sc for clinical application
inferredcites →https://doi.org/10.15379/2408-9788.2017.02openalex-snapshot
Continued Availability of the Tungsten-188/Rhenium-188 Generator to Enhance Therapeutic Utility of 188Re
inferredcites →https://doi.org/10.2174/1381612003399833openalex-snapshot
Preface
inferredcites →https://doi.org/10.2174/1568026611212230006openalex-snapshot
Beta-Emitting Radionuclides for Peptide Receptor Radionuclide Therapy
inferredcites →https://doi.org/10.2174/157340611796799249openalex-snapshot
86Y Based PET Radiopharmaceuticals: Radiochemistry and Biological Applications
inferredcites →https://doi.org/10.2174/1874471008666150312160440openalex-snapshot
Chemistry and bifunctional chelating agents for binding 177Lu
inferredcites →https://doi.org/10.2174/1874471008666150312160855openalex-snapshot
Production of No-Carrier Added Lutetium-177 by Irradiation of Enriched Ytterbium-176
inferredcites →https://doi.org/10.2174/1874471010801030135openalex-snapshot
Production of Alpha Emitters for Targeted Alpha Therapy
inferredcites →https://doi.org/10.2174/1874471011205030187openalex-snapshot
Scandium-44: Benefits of a Long-Lived PET Radionuclide Available from the 44Ti/44Sc Generator System
inferredcites →https://doi.org/10.22146/ijc.21143openalex-snapshot
Radiochemical Separation of 161Tb from Gd/Tb Matrix Using Ln Resin Column
inferredcites →https://doi.org/10.2310/7290.2010.00047sopenalex-snapshot
Intraoperative Imaging of Positron Emission Tomographic Radiotracers Using Cerenkov Luminescence Emissions
inferredcites →https://doi.org/10.2310/7290.2015.00025openalex-snapshot
Cyclotron Production of High–Specific Activity 55 Co and In Vivo Evaluation of the Stability of 55 Co Metal-Chelate-Peptide Complexes
inferredcites →https://doi.org/10.2967/jnumed.107.040378openalex-snapshot
Processing of Generator-Produced 68Ga for Medical Application
inferredcites →https://doi.org/10.2967/jnumed.112.107540openalex-snapshot
A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β−-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative
inferredcites →https://doi.org/10.2967/jnumed.114.141614openalex-snapshot
Promising Prospects for 44Sc-/47Sc-Based Theragnostics: Application of 47Sc for Radionuclide Tumor Therapy in Mice
inferredcites →https://doi.org/10.2967/jnumed.116.183194openalex-snapshot
German Multicenter Study Investigating 177 Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
inferredcites →https://doi.org/10.2967/jnumed.116.186338openalex-snapshot
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1
inferredcites →https://doi.org/10.2967/jnumed.117.204651openalex-snapshot
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 2
inferredcites →https://doi.org/10.3390/app3030593openalex-snapshot
Routine Production of 89Zr Using an Automated Module
inferredcites →https://doi.org/10.3390/ph10020056openalex-snapshot
The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y
inferredcites →https://doi.org/10.3390/ph7030353openalex-snapshot
Folate Receptor Targeted Alpha-Therapy Using Terbium-149
inferredcites →https://doi.org/10.7150/thno.20586openalex-snapshot
Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer
inferredcites →https://doi.org/10.7150/thno.26370openalex-snapshot
Comparative biodistribution analysis across four different 89Zr-monoclonal antibody tracers—The first step towards an imaging warehouse
inferredcites →https://doi.org/10.7892/boris.111641openalex-snapshot
First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced 44 Sc-DOTATOC: A Proof-of-Concept Study

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4534446openalex-extracted
inferred← citeshttps://doi.org/10.1002/cmdc.202100135openalex-snapshot
Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer
inferred← citeshttps://doi.org/10.1002/jlcr.3787openalex-snapshot
Theranostic approaches in nuclear oncology: From bench to bed
inferred← citeshttps://doi.org/10.1007/978-3-030-81261-4_14openalex-snapshot
Radiolabeled Antibodies for Cancer Radioimmunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-031-33533-4_22openalex-snapshot
Theranostic Radiopeptides in Nuclear Oncology: Design, Preclinical Screening, and Clinical Translation
inferred← citeshttps://doi.org/10.1007/978-3-031-84632-8_2openalex-snapshot
Nuclear Reactor-Based Production of Medical Radionuclides
inferred← citeshttps://doi.org/10.1007/s00259-021-05583-xopenalex-snapshot
Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box
inferred← citeshttps://doi.org/10.1007/s10967-026-11024-6openalex-snapshot
Radiochemical separation and purification of radionuclides for radiopharmaceutical development: selected advances and perspectives
inferred← citeshttps://doi.org/10.1016/b978-0-12-816386-3.00023-5openalex-snapshot
SPECT Radiochemistry
inferred← citeshttps://doi.org/10.1016/b978-0-12-822960-6.00005-3openalex-snapshot
Radionuclide generators
inferred← citeshttps://doi.org/10.1016/b978-0-12-822960-6.00044-2openalex-snapshot
Radiometals—Chemistry and radiolabeling
inferred← citeshttps://doi.org/10.1016/b978-0-12-822960-6.00078-8openalex-snapshot
Peptide radiopharmaceuticals for targeted diagnosis & therapy of human tumors
inferred← citeshttps://doi.org/10.1016/b978-0-12-822960-6.00183-6openalex-snapshot
Gamma camera imaging by radiolabeled gastrin/cholecystokinin analogs
inferred← citeshttps://doi.org/10.1016/b978-0-12-824147-9.00003-0openalex-snapshot
Culinary spices mediated biogenesis of nanoparticles for cancer and diabetes treatment
inferred← citeshttps://doi.org/10.1016/b978-0-323-99873-4.00023-2openalex-snapshot
Radiopharmaceuticals for molecular imaging and theranostics of glioblastoma
inferred← citeshttps://doi.org/10.1016/j.apradiso.2021.109599openalex-snapshot
Impact of prompt gamma emission of 44Sc on quantification in preclinical and clinical PET systems
inferred← citeshttps://doi.org/10.1016/j.apradiso.2021.110064openalex-snapshot
In vitro and in vivo response of PSMA-617 radiolabeled with CA and NCA lutetium-177
inferred← citeshttps://doi.org/10.1016/j.apradiso.2024.111284openalex-snapshot
Characterization and mapping of the neutron fields around Bruce Power’s 177Lu isotope production system
inferred← citeshttps://doi.org/10.1016/j.apradiso.2025.112144openalex-snapshot
Two-step extraction chromatography separation of 161Tb from 160Gd-enriched irradiated target material and verification of the [161Tb]TbCl3 suitability for radiolabelling
inferred← citeshttps://doi.org/10.1016/j.apradiso.2025.112213openalex-snapshot
Activity standardization of 47Sc by LS methods
inferred← citeshttps://doi.org/10.1016/j.apradiso.2025.112408openalex-snapshot
Gamma-ray spectrometry measurements for quality assessment of scandium-47 produced by neutron irradiation of calcium-46
inferred← citeshttps://doi.org/10.1016/j.apradiso.2026.112420openalex-snapshot
Activity standardization and determination of the half-life of Tb-161
inferred← citeshttps://doi.org/10.1016/j.apradiso.2026.112450openalex-snapshot
Validation of MCNP6 and FISPACT-II calculations to predict the activation of selected beta emitters produced in the Budapest Research Reactor
inferred← citeshttps://doi.org/10.1016/j.ccr.2022.215005openalex-snapshot
Zirconium immune-complexes for PET molecular imaging: Current status and prospects
inferred← citeshttps://doi.org/10.1016/j.ejmp.2025.105077openalex-snapshot
Monte Carlo study of the eye lens exposure of medical staff administering Sc-47 and Cu-67 labelled radiopharmaceuticals
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2020.119314openalex-snapshot
Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2020.07.003openalex-snapshot
Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2020.11.005openalex-snapshot
Development and validation of the HPLC method for quality control of radiolabelled DOTA-TATE and DOTA-TOC preparations
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2024.108910openalex-snapshot
Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes
inferred← citeshttps://doi.org/10.1016/j.radphyschem.2023.110821openalex-snapshot
Study of (p,x) reactions in the natCaO targets
inferred← citeshttps://doi.org/10.1016/j.radphyschem.2023.111290openalex-snapshot
Excitation functions of proton-induced nuclear reactions on natCaCO3 up to 60 MeV
inferred← citeshttps://doi.org/10.1016/j.seppur.2024.127400openalex-snapshot
Robust electrochemical method for separation of theranostic 44Sc/47Sc pair of radiometals
inferred← citeshttps://doi.org/10.1016/j.trac.2022.116900openalex-snapshot
Microbial metabolites diversity and their potential as molecular template for the discovery of new fluorescent and radiopharmaceutical probes
inferred← citeshttps://doi.org/10.1021/acs.inorgchem.6c01482openalex-snapshot
An Evaluation of Cage Amine Sarcophagine Ligands for the Synthesis of Cobalt Radiopharmaceuticals
inferred← citeshttps://doi.org/10.1021/acsomega.4c00187openalex-snapshot
Synthesis and Evaluation of [64Cu]Cu-NOTA-HFn for PET Imaging of Transferrin Receptor 1 Expression in Nasopharyngeal Carcinoma
inferred← citeshttps://doi.org/10.1021/jacs.1c05339openalex-snapshot
Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate Sizes
inferred← citeshttps://doi.org/10.1021/jacs.3c02325openalex-snapshot
A Radioluminescent Metal–Organic Framework for Monitoring 225 Ac in Vivo
inferred← citeshttps://doi.org/10.1038/s41557-020-00598-7openalex-snapshot
Developing the 134Ce and 134La pair as companion positron emission tomography diagnostic isotopes for 225Ac and 227Th radiotherapeutics
inferred← citeshttps://doi.org/10.1038/s42004-020-0307-0openalex-snapshot
Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals
inferred← citeshttps://doi.org/10.1039/d4md00591kopenalex-snapshot
Enhancing the radionuclide theranostic concept through the radiohybrid approach
inferred← citeshttps://doi.org/10.1055/a-1474-8976openalex-snapshot
Aktuelle radiopharmazeutische Entwicklungen für die theranostische Anwendung
inferred← citeshttps://doi.org/10.1055/a-1525-6335openalex-snapshot
Aktuelle radiopharmazeutische Entwicklungen für die theranostische Anwendung
inferred← citeshttps://doi.org/10.1088/1361-6560/abc811openalex-snapshot
Preliminary dosimetric analysis of DOTA-folate radiopharmaceutical radiolabelled with 47 Sc produced through nat V(p,x) 47 Sc cyclotron irradiation
inferred← citeshttps://doi.org/10.1134/s1070363221020080openalex-snapshot
Complexation of Scandium with Oxabis(ethylenenitrilo)tetramethylenephosphonic Acid and Applicability of Its 44Sc-Labelled Analogue as Bone-Seeking Agent
inferred← citeshttps://doi.org/10.11606/t.85.2020.tde-23122020-094716openalex-snapshot
Obtenção de kit de PSMA-617 para pronta marcação com lutécio-177 e sua avaliação na aplicabilidade no tratamento do câncer de próstata
inferred← citeshttps://doi.org/10.1186/s41181-020-00108-7openalex-snapshot
Automated, cassette-based isolation and formulation of high-purity [61Cu]CuCl2 from solid Ni targets
inferred← citeshttps://doi.org/10.1186/s41181-021-00131-2openalex-snapshot
Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements
inferred← citeshttps://doi.org/10.1186/s41181-023-00220-4openalex-snapshot
The Curies’ element: state of the art and perspectives on the use of radium in nuclear medicine
inferred← citeshttps://doi.org/10.1186/s41181-023-00232-0openalex-snapshot
Chromatographic separation of silver-111 from neutron-irradiated palladium target: toward direct labeling of radiotracers
inferred← citeshttps://doi.org/10.1186/s41181-023-00233-zopenalex-snapshot
Production of the PET radionuclide 61Cu via the 62Ni(p,2n)61Cu nuclear reaction
inferred← citeshttps://doi.org/10.1186/s41181-025-00332-zopenalex-snapshot
Ac-225 radiochemistry through the lens of [225Ac]Ac-DOTA-TATE
inferred← citeshttps://doi.org/10.1515/ract-2025-0043openalex-snapshot
Development and evaluation of 177 Lu-imatinib: radiolabeling and cell culture studies
inferred← citeshttps://doi.org/10.1515/ract-2025-0083openalex-snapshot
From bench to batch: scaling up copper-67 production via the 70 Zn(p,α) 67 Cu nuclear reaction
inferred← citeshttps://doi.org/10.1515/revic-2020-0021openalex-snapshot
Recent advances in the synthesis of (99mTechnetium) based radio-pharmaceuticals
inferred← citeshttps://doi.org/10.3389/fmed.2021.647379openalex-snapshot
Clickable Radiocomplexes With Trivalent Radiometals for Cancer Theranostics: In vitro and in vivo Studies
inferred← citeshttps://doi.org/10.3389/fmed.2021.678452openalex-snapshot
Emerging Radionuclides in a Regulatory Framework for Medicinal Products – How Do They Fit?
inferred← citeshttps://doi.org/10.3389/fnume.2022.1058388openalex-snapshot
Radiometal chelators for infection diagnostics
inferred← citeshttps://doi.org/10.3390/cancers13225776openalex-snapshot
Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals
inferred← citeshttps://doi.org/10.3390/ijms25115954openalex-snapshot
Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues
inferred← citeshttps://doi.org/10.3390/molecules25174012openalex-snapshot
Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
inferred← citeshttps://doi.org/10.3390/pharmaceutics13040506openalex-snapshot
Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with 68Ga and 177Lu as Potential Theranostic Agent for Colon Cancer
inferred← citeshttps://doi.org/10.3390/pharmaceutics15041240openalex-snapshot
Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals
inferred← citeshttps://doi.org/10.3769/radioisotopes.71.161openalex-snapshot
Productions and Application to Life Science of Useful Accelerator-produced Radioisotopes
inferred← citeshttps://doi.org/10.55262/fabadeczacilik.1172020openalex-snapshot
Monoclonal Antibodies and Immuno-PET Imaging: An Overview
inferred← citeshttps://doi.org/10.5772/intechopen.95438openalex-snapshot
Radiopharmaceutical Precursors for Theranostics
inferred← citeshttps://doi.org/10.6084/m9.figshare.26663443openalex-snapshot
Additional file 1 of Production of the PET radionuclide 61Cu via the 62Ni(p,2n)61Cu nuclear reaction
inferred← citeshttps://doi.org/10.70675/f0aee498zbad1z4fe3zbd0azc8bf9a7dc0a1openalex-snapshot
Développement d’azaBODIPYs fonctionnalisables pour la conception de sondes d’imagerie bimodale et d’agents théranostiques
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.